Please Scroll Down to See Forums Below 
TIROMEL T3 - 25 mcg/tab 100 tabs $60
Condition: New product
Supplier:AbdiBrahim
Chemical Name:Liothyronine Sodium'
Comes In:25 MCG tab
Dosage: 25-100 mcg/day
Active time: 5-7 days
Class:Synthetic thyroid hormone
Chemical Name:Liothyronine Sodium'
Comes In:25 MCG tab
Dosage: 25-100 mcg/day
Active time: 5-7 days
Class:Synthetic thyroid hormone
Loss that unwanted body fat that's being problematic..
Boost your metabolism today, and refined that waist line
Boost your metabolism today, and refined that waist line
Pharmaceutical Grade Cytomel
The mission statement from this popular Pharma-group
With its roots going back to a small pharmacy established by the Pharmacist Abdi İbrahim Bey in the Küçükmustafapaşa district of Istanbul in 1912, Abdi İbrahim is on a journey of “healing” with commitment and determination since that day.
The focus of our business is human health, a fact that places an enormous responsibility on us. With this in mind, we do not see ourselves as a mere producer of pharmaceuticals. We have been endeavoring to heal the future and the lives we touch, for the last 106 years.
Today, with the largest portfolio in the industry with over 180 brands and more than 350 products, Abdi İbrahim remains the sector leader in box sales and turnover—a title it has held since 2003. We continue our investments and operations around the world as we shoulder our responsibility of healing lives with 4.000 employees serving in 50 countries from the EU to Canada and North Africa to Asia. Every achievement we accomplish, every target we reach adds to our determination for serving our company, our industry, and our country. In our intense efforts, our eyes are set on our goals of making this pride sustainable and becoming a strong international player.
Driven by its deep-rooted history in Turkish pharmaceuticals industry and its forward-looking, dynamic structure and human resources, Abdi İbrahim is taking determined steps towards its targets as we, working together, take our century-old company into the future.
And we will continue working together with enthusiasm as we move towards our goal of becoming one of the world’s top 100 pharmaceutical companies by 2020.
As with always, we will represent our country and industry in the world with courage, passion, and responsibility.
Sincerely,
Nezih Barut
Chairman
With its roots going back to a small pharmacy established by the Pharmacist Abdi İbrahim Bey in the Küçükmustafapaşa district of Istanbul in 1912, Abdi İbrahim is on a journey of “healing” with commitment and determination since that day.
The focus of our business is human health, a fact that places an enormous responsibility on us. With this in mind, we do not see ourselves as a mere producer of pharmaceuticals. We have been endeavoring to heal the future and the lives we touch, for the last 106 years.
Today, with the largest portfolio in the industry with over 180 brands and more than 350 products, Abdi İbrahim remains the sector leader in box sales and turnover—a title it has held since 2003. We continue our investments and operations around the world as we shoulder our responsibility of healing lives with 4.000 employees serving in 50 countries from the EU to Canada and North Africa to Asia. Every achievement we accomplish, every target we reach adds to our determination for serving our company, our industry, and our country. In our intense efforts, our eyes are set on our goals of making this pride sustainable and becoming a strong international player.
Driven by its deep-rooted history in Turkish pharmaceuticals industry and its forward-looking, dynamic structure and human resources, Abdi İbrahim is taking determined steps towards its targets as we, working together, take our century-old company into the future.
And we will continue working together with enthusiasm as we move towards our goal of becoming one of the world’s top 100 pharmaceutical companies by 2020.
As with always, we will represent our country and industry in the world with courage, passion, and responsibility.
Sincerely,
Nezih Barut
Chairman
